EMA Highlights: EMA gives green light for infant tumour drug
by Gary Finnegan – The European drug regulator has given a paediatric-use marketing authorisation (PUMA) for Hemangiol to treat proliferation of infantile haemangioma.
by Gary Finnegan – The European drug regulator has given a paediatric-use marketing authorisation (PUMA) for Hemangiol to treat proliferation of infantile haemangioma.
Dysfunctional version of normally protective protein that makes HDL found to promote inflammation and coronary artery disease.
Dysfunctional version of normally protective protein that makes HDL found to promote inflammation and coronary artery disease.
by Bruce Sylvester: A study published on Feb. 27, 2014 in The Lancet suggests that amyotrophic lateral sclerosis (ALS) patients who are mildly obese are more likely to… read more.
by Bruce Sylvester: Newly developed contrast MRI can help physicians predict which atrial fibrillation people have the best chance of benefiting from catheter ablation, researchers reported on Feb…. read more.
by Thomas R. Collins: Women who are diagnosed with early stage breast cancer who also carry a mutation on the BRCA breast cancer gene are less likely to… read more.
by Bruce Sylvester: Electronic stimulation therapy to the upper airway during sleep is effective in reducing obstructive sleep apnea (OSA), researchers reported in the Jan. 9, 2014 issue… read more.
by Bruce Sylvester: Ongoing statin treatment appears to prevent delirium in critically ill patients who had taken a statin prior to hospitalization, researchers reported online on Jan. 17,… read more.
by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.
by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.
by Bruce Sylvester: Topiramate, an FDA-approved anticonvulsant drug which had been shown to reduce drinking in patients committed to complete abstinence, appears to help problem drinkers whose want… read more.
“Despite already being rolled-out in many countries, our study is the first to look at the feasibility of the Xpert test in a real-life clinical setting in southern… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.